Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Greenwood Genetic Center Diagnostic Laboratories, |
RCV002291382 | SCV002583652 | likely pathogenic | TNNT2-related disorder | 2022-08-24 | criteria provided, single submitter | clinical testing | PP3_Strong, PM1, PM2 |
Color Diagnostics, |
RCV003533157 | SCV004359946 | uncertain significance | Cardiomyopathy | 2022-05-16 | criteria provided, single submitter | clinical testing | This variant alters the intron 8 canonical splice acceptor site of the TNNT2 gene. Splice prediction tools suggest that this variant may disrupt RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The role of loss-of-function TNNT2 truncation and splice variants in autosomal dominant cardiovascular disorders is not clearly established. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |